NR 507 Final Exam: Advanced Pathophysiology V2
Updated and Latest Questions and Correct Answers with
Rationale
1. Which of the following describes the physiological mechanism of atrophy in cellular
adaptation?
A. A decrease in cell size due to loss of cellular substance
B. An increase in cell size and functional activity
C. The replacement of one adult cell type by another
D. An increase in the total number of cells in a tissue
Ans: A
Rationale: Atrophy represents a decrease in cell size and occurs when there is a reduction in workload
or nutrition. This process is often a survival mechanism that allows the cell to decrease its metabolic
demands. It differs from hypertrophy, which involves an increase in cell size rather than a decrease.
Cellular substance such as proteins and organelles are systematically reduced to conserve energy. This
adaptation is frequently seen in skeletal muscle during periods of prolonged immobilization or disuse.
Understanding these adaptive changes is essential for identifying the underlying causes of tissue wasting
in clinical settings.
,2. In the context of the Renin-Angiotensin-Aldosterone System (RAAS), what is the direct
effect of Angiotensin II on the vasculature?
A. Potent systemic vasoconstriction
B. Increased capillary permeability
C. Potent systemic vasodilation
D. Inhibition of smooth muscle contraction
Ans: A
Rationale: Angiotensin II is a powerful vasoconstrictor that significantly increases systemic vascular
resistance and blood pressure. It acts directly on the AT1 receptors found on the smooth muscle cells of
the blood vessels. This effect is a primary mechanism for the rapid elevation of blood pressure in
response to hypotension. Furthermore, it stimulates the release of aldosterone from the adrenal cortex to
promote sodium retention. By narrowing the arterial lumen, it ensures that perfusion is maintained to
vital organs during stress. Chronic overactivation of this pathway is a major contributor to the
development of hypertension.
,3. Which type of hypersensitivity reaction is primarily mediated by IgE antibodies and mast
cell degranulation?
A. Type I Hypersensitivity
B. Type II Hypersensitivity
C. Type III Hypersensitivity
D. Type IV Hypersensitivity
Ans: A
Rationale: Type I hypersensitivity is an immediate allergic reaction triggered by the binding of an
allergen to IgE on mast cells. This binding causes the release of inflammatory mediators like histamine,
leukotrienes, and prostaglandins into the tissue. Common examples of this reaction include allergic
rhinitis, asthma, and systemic anaphylaxis. Type II and Type III reactions involve different mechanisms
such as IgG/IgM binding or immune complex deposition. Type IV is unique because it is mediated by T-
cells rather than antibodies. Identifying the specific type of hypersensitivity is critical for selecting the
appropriate pharmacological intervention for patients.
4. What is the hallmark physiological finding in patients with Nephrotic Syndrome?
A. Gross hematuria and hypertension
B. Reduced glomerular filtration rate with azotemia
C. Severe proteinuria exceeding 3.5 grams per day
D. Formation of uric acid crystals in the renal tubules
Ans: C
, Rationale: Nephrotic syndrome is characterized by massive proteinuria resulting from increased
glomerular permeability to plasma proteins. The loss of albumin leads to a decrease in plasma oncotic
pressure and the subsequent development of edema. Patients typically present with hypoalbuminemia,
hyperlipidemia, and significant peripheral swelling. This condition is distinct from nephritic syndrome,
which is more commonly associated with hematuria and inflammation. The excessive protein loss can
also lead to a hypercoagulable state due to the depletion of antithrombin III. Managing the underlying
glomerular injury is the primary focus of long-term clinical treatment.
5. Which hormone is primarily responsible for the stimulation of red blood cell production in
response to hypoxia?
A. Thrombopoietin
B. Leukopoietin
C. Erythropoietin
D. Aldosterone
Ans: C
Rationale: Erythropoietin is a glycoprotein hormone produced primarily by the kidneys in response to
low oxygen levels. It travels through the bloodstream to the bone marrow where it stimulates the
proliferation of erythrocyte precursors. This mechanism ensures that the body maintains adequate
oxygen-carrying capacity in various environmental conditions. Patients with chronic kidney disease often
suffer from anemia because their kidneys cannot produce sufficient amounts of this hormone. The
feedback loop is highly sensitive to changes in atmospheric pressure or internal oxygen demand.
Exogenous erythropoietin is frequently used to treat anemia in specialized patient populations.
Updated and Latest Questions and Correct Answers with
Rationale
1. Which of the following describes the physiological mechanism of atrophy in cellular
adaptation?
A. A decrease in cell size due to loss of cellular substance
B. An increase in cell size and functional activity
C. The replacement of one adult cell type by another
D. An increase in the total number of cells in a tissue
Ans: A
Rationale: Atrophy represents a decrease in cell size and occurs when there is a reduction in workload
or nutrition. This process is often a survival mechanism that allows the cell to decrease its metabolic
demands. It differs from hypertrophy, which involves an increase in cell size rather than a decrease.
Cellular substance such as proteins and organelles are systematically reduced to conserve energy. This
adaptation is frequently seen in skeletal muscle during periods of prolonged immobilization or disuse.
Understanding these adaptive changes is essential for identifying the underlying causes of tissue wasting
in clinical settings.
,2. In the context of the Renin-Angiotensin-Aldosterone System (RAAS), what is the direct
effect of Angiotensin II on the vasculature?
A. Potent systemic vasoconstriction
B. Increased capillary permeability
C. Potent systemic vasodilation
D. Inhibition of smooth muscle contraction
Ans: A
Rationale: Angiotensin II is a powerful vasoconstrictor that significantly increases systemic vascular
resistance and blood pressure. It acts directly on the AT1 receptors found on the smooth muscle cells of
the blood vessels. This effect is a primary mechanism for the rapid elevation of blood pressure in
response to hypotension. Furthermore, it stimulates the release of aldosterone from the adrenal cortex to
promote sodium retention. By narrowing the arterial lumen, it ensures that perfusion is maintained to
vital organs during stress. Chronic overactivation of this pathway is a major contributor to the
development of hypertension.
,3. Which type of hypersensitivity reaction is primarily mediated by IgE antibodies and mast
cell degranulation?
A. Type I Hypersensitivity
B. Type II Hypersensitivity
C. Type III Hypersensitivity
D. Type IV Hypersensitivity
Ans: A
Rationale: Type I hypersensitivity is an immediate allergic reaction triggered by the binding of an
allergen to IgE on mast cells. This binding causes the release of inflammatory mediators like histamine,
leukotrienes, and prostaglandins into the tissue. Common examples of this reaction include allergic
rhinitis, asthma, and systemic anaphylaxis. Type II and Type III reactions involve different mechanisms
such as IgG/IgM binding or immune complex deposition. Type IV is unique because it is mediated by T-
cells rather than antibodies. Identifying the specific type of hypersensitivity is critical for selecting the
appropriate pharmacological intervention for patients.
4. What is the hallmark physiological finding in patients with Nephrotic Syndrome?
A. Gross hematuria and hypertension
B. Reduced glomerular filtration rate with azotemia
C. Severe proteinuria exceeding 3.5 grams per day
D. Formation of uric acid crystals in the renal tubules
Ans: C
, Rationale: Nephrotic syndrome is characterized by massive proteinuria resulting from increased
glomerular permeability to plasma proteins. The loss of albumin leads to a decrease in plasma oncotic
pressure and the subsequent development of edema. Patients typically present with hypoalbuminemia,
hyperlipidemia, and significant peripheral swelling. This condition is distinct from nephritic syndrome,
which is more commonly associated with hematuria and inflammation. The excessive protein loss can
also lead to a hypercoagulable state due to the depletion of antithrombin III. Managing the underlying
glomerular injury is the primary focus of long-term clinical treatment.
5. Which hormone is primarily responsible for the stimulation of red blood cell production in
response to hypoxia?
A. Thrombopoietin
B. Leukopoietin
C. Erythropoietin
D. Aldosterone
Ans: C
Rationale: Erythropoietin is a glycoprotein hormone produced primarily by the kidneys in response to
low oxygen levels. It travels through the bloodstream to the bone marrow where it stimulates the
proliferation of erythrocyte precursors. This mechanism ensures that the body maintains adequate
oxygen-carrying capacity in various environmental conditions. Patients with chronic kidney disease often
suffer from anemia because their kidneys cannot produce sufficient amounts of this hormone. The
feedback loop is highly sensitive to changes in atmospheric pressure or internal oxygen demand.
Exogenous erythropoietin is frequently used to treat anemia in specialized patient populations.
